Immunohistochemical Markers as a Surrogate Method for Differentiation of Luminal Subtypes of Breast Cancer and Their Prognostic Significance
- PMID: 33187863
- DOI: 10.1016/j.clbc.2020.07.016
Immunohistochemical Markers as a Surrogate Method for Differentiation of Luminal Subtypes of Breast Cancer and Their Prognostic Significance
Comment on
-
Identification of Luminal Subtypes of Breast Carcinoma Using Surrogate Immunohistochemical Markers and Ascertaining Their Prognostic Relevance.Clin Breast Cancer. 2020 Oct;20(5):382-389. doi: 10.1016/j.clbc.2020.03.012. Epub 2020 Apr 6. Clin Breast Cancer. 2020. PMID: 32467058
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
